Most important, an efficient reversible negative regulation of IL2 and IFNγ secretion with subsequent impairment of cancer cell killing demonstrated that CAR-T cells can be turned off in case of excessive cytokine release, thereby avoiding potentially adverse effects, which needs to be tested in the future in vivo as well. This evidence concerns the gene IL2 and cancer.